[HTML][HTML] Cancer and radiation therapy: current advances and future directions

R Baskar, KA Lee, R Yeo, KW Yeoh - International journal of …, 2012 - ncbi.nlm.nih.gov
In recent years remarkable progress has been made towards the understanding of proposed
hallmarks of cancer development and treatment. However with its increasing incidence, the …

[HTML][HTML] De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of …

L Masterson, D Moualed, ZW Liu, JEF Howard… - European journal of …, 2014 - Elsevier
Iatrogenic complications associated with current treatment protocols for oropharyngeal
squamous cell carcinoma are noted to cause high rates of acute and chronic morbidity. The …

Use of larynx-preservation strategies in the treatment of laryngeal cancer: American Society of Clinical Oncology clinical practice guideline update

AA Forastiere, N Ismaila, JS Lewin… - Journal of Clinical …, 2018 - ascopubs.org
Purpose To update the guideline recommendations on the use of larynx-preservation
strategies in the treatment of laryngeal cancer. Methods An Expert Panel updated the …

CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG …

CL Brouwer, RJHM Steenbakkers, J Bourhis… - Radiotherapy and …, 2015 - Elsevier
Purpose The objective of this project was to define consensus guidelines for delineating
organs at risk (OARs) for head and neck radiotherapy for routine daily practice and for …

Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study

AM Chen, C Felix, PC Wang, S Hsu, V Basehart… - The Lancet …, 2017 - thelancet.com
Background Head and neck cancers positive for human papillomavirus (HPV) are
exquisitely radiosensitive. We investigated whether chemoradiotherapy with reduced-dose …

Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer

M Feng, JM Moran, T Koelling, A Chughtai… - International Journal of …, 2011 - Elsevier
PURPOSE: Cardiac toxicity is an important sequela of breast radiotherapy. However, the
relationship between dose to cardiac structures and subsequent toxicity has not been well …

Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis

M Machtay, J Moughan, A Trotti, AS Garden… - Journal of Clinical …, 2008 - ascopubs.org
Purpose Concurrent chemoradiotherapy (CCRT) for squamous cell carcinoma of the head
and neck (SCCHN) increases both local tumor control and toxicity. This study evaluates …

Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3 …

C Nutting, L Finneran, J Roe, MA Sydenham… - The Lancet …, 2023 - thelancet.com
Background Most newly diagnosed oropharyngeal and hypopharyngeal cancers are treated
with chemoradiotherapy with curative intent but at the consequence of adverse effects on …

Late dysphagia after radiotherapy‐based treatment of head and neck cancer

KA Hutcheson, JS Lewin, DA Barringer, A Lisec… - Cancer, 2012 - Wiley Online Library
BACKGROUND: Changing trends in head and neck cancer (HNC) merit an understanding
of the late effects of therapy, but few studies examine dysphagia beyond 2 years of …

[HTML][HTML] Treatment de-escalation for HPV-driven oropharyngeal cancer: where do we stand?

H Mirghani, P Blanchard - Clinical and translational radiation oncology, 2018 - Elsevier
HPV-driven oropharyngeal cancers have significantly better survival rates than tobacco and
alcohol induced head and neck cancers. As HPV-positive patients are younger, healthier …